Utilization of magnetic resonance imaging in breast cancer screening

Current Oncology

Volumn 22, Issue 5, 2015, Pages e332-e335

  Lin, D ^a   Moy, L ^a   Axelrod, D ^a   Smith, Julia ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN;

BREAST CANCER; CANCER SCREENING; DIAGNOSTIC TEST ACCURACY STUDY; FAMILY HISTORY; GENE MUTATION; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; MAMMOGRAPHY; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONCOGENE; OVARY CANCER; OVERALL SURVIVAL; SENSITIVITY AND SPECIFICITY;

EID: 84944526629     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.22.2882     Document Type: Note

References (31)

1. Warner E. Clinical practice. Breast-cancer screening. N Engl J Med 2011 15;365:1025-32.
2. U.S. Preventive Services Task Force (uspstf). Breast Cancer: Screening [final update summary, Web page]. Rockville, MD: uspstf; 2015. [Avai lable at: http://www.uspreventive servicestaskforce.org/Page/Document/UpdateSummary Final/breast-cancer-screening; cited 31 August 2015]
3. Saslow D, Boetes C, Burke W, et al. on behalf of the American Cancer Society Breast Cancer Advisory Group. American Cancer Society guidelines for breast screening with mri as an adjunct to mammography. CA Cancer J Clin 2007;57:75-89. [Erratum in: CA Cancer J Clin 2007;57:185]
4. Kriege M, Brekelmans CT, Boetes C, et al. on behalf of the Magnetic Resonance Imaging Screening Study Group. Efficacy of mri and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004;351:427-37.
5. Leach MO, Boggis CR, Dixon AK, et al. on behalf of the maribs study group. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (maribs). Lancet 2005;365:1769-78. [Erratum in: Lancet 2005;365:1848]
6. Warner E, Plewes DB, Hill KA, et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004;292:1317-25.
7. Kriege M, Brekelmans CT, Obdeijn IM, et al. Factors affecting sensitivity and specificity of screening mammography and mri in women with an inherited risk for breast cancer. Breast Cancer Res Treat 2006;100:109-19.
8. Riedl CC, Luft N, Bernhart C, et al. Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density. J Clin Oncol 2015;33:1128-35.
9. Chiarelli AM, Prummel MV, Muradali D, et al. Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program. J Clin Oncol 2014;32:2224-30.
10. Kuhl CK, Schrading S, Bieling HB, et al. mri for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007;370:485-92.
11. Antoniou A, Pharoah PD, Narod S, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003;72:1117-30.
12. Gillman J, Toth HK, Moy L. The role of dynamic contrastenhanced screening breast mri in populations at increased risk for breast cancer. Womens Health (Lond Engl) 2014;10:609-22.
13. Kuhl CK, Schrading S, Leutner CC, et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005;23:8469-76.
14. Schrading S, Kuhl CK. mri screening of women at average risk of breast cancer [abstract 21]. J Clin Oncol 2013;:. [Avai lable onl ine at: http://meetingl ibrary.asco.org/ content/119461-135; cited 20 August 2015]
15. Schrading S, Strobel K, Kuhl CK. mri screening of women at average risk of breast cancer [abstract S1-09]. Presented at: San Antonio Breast Cancer Symposium; San Antonio, TX; 13 December 2013. [Available online at: http://www. abstracts2view.com/sabcs13/view.php?nu=SABCS13L_1168; cited 20 August 2015]
16. Berg WA. How well does supplemental screening magnetic resonance imaging work in high-risk women? J Clin Oncol 2014;32:2193-6.
17. Phi XA, Houssami N, Obdeijn IM, et al. Magnetic resonance imaging improves breast screening sensitivity in BRCA mutation carriers age ≥ 50 years: evidence from an individual patient data meta-analysis. J Clin Oncol 2015;33:349-56.
18. Mann RM, Balleyguier C, Baltzer PA, et al. on behalf of the European Society of Breast Imaging (eusobi), with language review by Europa Donna-The European Breast Cancer Coalition. Breast mri: eusobi recommendations for women's information. Eur Radiol 2015;:[Epub ahead of print].
19. Sardanelli F, Rescinito G, Giordano GD, Calabrese M, Parodi RC. mr dynamic enhancement of breast lesions: high temporal resolution during the first-minute versus eight-minute study. J Comput Assist Tomogr 2000;24:724-31.
20. Buadu LD, Murakami J, Murayama S, et al. Breast lesions: correlation of contrast medium enhancement patterns on MR images with histopathologic findings and tumor angiogenesis. Radiology 1996;200:639-49.
21. Leong LC, Gombos EC, Jagadeesan J, Fook-Chong SM. mri kinetics with volumetric analysis in correlation with hormonal receptor subtypes and histologic grade of invasive breast cancers. AJR Am J Roentgenol 2015;204:W348-56.
22. Szabó BK, Aspelin P, Kristoffersen Wiberg M, Tot T, Boné B. Invasive breast cancer: correlation of dynamic MR features with prognostic factors. Eur Radiol 2003;13:2425-35.
23. Grimm LJ, Soo MS, Yoon S, Kim C, Ghate SV, Johnson KS. Abbreviated screening protocol for breast mri: a feasibility study. Acad Radiol 2015;22:1157-62.
24. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (mri): first postcontrast subtracted images and maximumintensity projection-a novel approach to breast cancer screening with mri. J Clin Oncol 2014;32:2304-10.
25. Mango VL, Morris EA, David Dershaw D, et al. Abbreviated protocol for breast mri: are multiple sequences needed for cancer detection? Eur J Radiol 2015; 84:65-70.
26. Kuhl CK, Schrading S, Strobel K, Schild HH, Hilgers RD, Bieling HB. Abbreviated breast magnetic resonance imaging (mri): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with mri. J Clin Oncol 2014; 32:2304-10.
27. Mann RM, Mus RD, van Zelst J, Geppert C, Karssemeijer N, Platel B. A novel approach to contrast-enhanced breast magnetic resonance imaging for screening: high-resolution ultrafast dynamic imaging. Invest Radiol 2014;49:579-85.
28. Veltman J, Stoutjesdijk M, Mann R, et al. Contrast-enhanced magnetic resonance imaging of the breast: the value of pharmacokinetic parameters derived from fast dynamic imaging during initial enhancement in classifying lesions. Eur Radiol 2008;18:1123-33.
29. Saadatmand S, Obdeijn IM, Rutgers EJ, et al. Survival benefit in women with BRCA1 mutation or familial risk in the mri screening study (mrisc). Int J Cancer 2015;137:1729-38.
30. Evans DG, Kesavan N, Lim Y, et al. on behalf of the maribs group. mri breast screening in high-risk women: cancer detection and survival analysis. Breast Cancer Res Treat 2014;145:663-72.
31. Kaniklidis C on behalf of the No Surrender Breast Cancer Foundation. Beyond the mammography debate: a moderate perspective. Curr Oncol 2015;22:220-9.